| Fusemachines Rolls Out Compliance Features in HireFoundry.ai to Help Enterprises Navigate Evolving U.S. State AI Hiring Laws |
Globe Newswire |
10/29 |
08:00 |
| Cemtrex Reports Preliminary Fourth Quarter and Fiscal Year 2026 Results |
Globe Newswire |
10/29 |
08:00 |
| Commerce Named as a Challenger in 2026 Gartner® Magic Quadrant™ for Digital Commerce Platforms |
Globe Newswire |
10/29 |
08:00 |
| Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2026 Financial Results on November 5, 2026 |
Globe Newswire |
10/29 |
08:00 |
| NeuroOne® Announces Peer-Reviewed Publication of Initial Clinical Experience with OneRF® Trigeminal Nerve Ablation System |
Globe Newswire |
10/29 |
08:00 |
| Aon and SAGE Bring Field-Level Agricultural Intelligence to Crop Insurance |
Globe Newswire |
10/29 |
08:00 |
| Nexxen to Announce Third Quarter 2026 Financial Results on November 12, 2026 |
Globe Newswire |
10/29 |
08:00 |
| Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026 |
Globe Newswire |
10/29 |
08:00 |
| Oak Hill Bio to Present at Upcoming Investor Conferences |
Globe Newswire |
10/29 |
08:00 |
| Integer Holdings Corporation Reports Third Quarter 2026 Results |
Globe Newswire |
10/29 |
08:00 |
| Field Service Teams Using AI on Industry-Tailored Platforms Are 5X as Likely to Report Significant Gains in Technician Morale: Praxedo Study |
Globe Newswire |
10/29 |
08:00 |
| Acrivon Announces Late-Breaking Oral Plenary Presentation of Early Phase 1/2 Clinical Results in AP3-Predicted Tumors for its First-in-Class WEE1/PKMYT1 Inhibitor ACR-2316 at the 38th EORTC-NCI-AACR Symposium |
Globe Newswire |
10/29 |
08:00 |
| Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
10/29 |
08:00 |
| Immutep Quarterly Activities Report Q1 FY27 |
Globe Newswire |
10/29 |
08:00 |
| VYSTAR ENTERS STRATEGIC PARTNERSHIP INTO THE MOTION PICTURE INDUSTRY, WITH FILM AND TOKENIZATION CONTRACTS |
Globe Newswire |
10/29 |
08:00 |
| CytomX Therapeutics to Report Third Quarter 2026 Financial Results on November 5, 2026 |
Globe Newswire |
10/29 |
08:00 |
| Intellia Therapeutics Announces Upcoming Lonvoguran Ziclumeran (Lonvo-z) Investor Event and Seven Presentations at ACAAI 2026 |
Globe Newswire |
10/29 |
08:00 |
| Diagonal Therapeutics Appoints Industry Veteran Jeremy Bender, Ph.D., M.B.A., as Chair of the Board of Directors |
Globe Newswire |
10/29 |
08:00 |
| Marvix AI Partners with Unlimited Systems to Bring Smarter Clinical Documentation AI to Specialty Practices |
Globe Newswire |
10/29 |
07:46 |
| Saia Appoints Todd Fowler to Board of Directors |
Globe Newswire |
10/29 |
07:31 |
| FTI Consulting Reports Record Third Quarter 2026 Revenues of $1.013 Billion, With Growth Across All Five Business Segments |
Globe Newswire |
10/29 |
07:30 |
| Leonardo DRS Announces Financial Results for Third Quarter 2026 |
Globe Newswire |
10/29 |
07:30 |
| DT Midstream Reports Strong Third Quarter 2026 Results; Raises Adjusted EBITDA Guidance |
Globe Newswire |
10/29 |
07:30 |
| Laureate Education Reports Financial Results for The Third Quarter And Nine Months Ended September 30, 2026 |
Globe Newswire |
10/29 |
07:30 |
| CervoMed Announces Publication of Two Peer-Reviewed Research Articles Supporting Neflamapimod as a Potential Treatment for Dementia with Lewy Bodies (DLB) |
Globe Newswire |
10/29 |
07:30 |
